From data to strategic knowledge
We transform public information into market insights that drive sustainable and competitive decisions.
The Leading Database of the Public Healthcare Market
Public healthcare procurement represents approximately 11% of GDP in Spain and Portugal. It is one of the pillars of the pharmaceutical and healthcare technology sector, and at the same time, one of the most complex and competitive environments. Its documentary magnitude and constant regulatory evolution require method, experience, and expert analysis of each opportunity.
At Acobur, we have been analyzing this market for nearly three decades. Our information system, the most comprehensive in the public healthcare sector, brings together more than 16 years of exhaustive data, cataloged by file and organized with a high level of detail and specific analysis. Every day, our team processes information from multiple official sources to ensure that companies in the sector have updated, reliable, and relevant data.
Medical technology and healthcare service companies access this information through WeTender MANAGE, the base module for communication, management, and commercial planning. Pharmaceutical laboratories do so through WeTender ANALYTICS, designed for price analysis, adjudications, and purchasing trends in the hospital setting.
*Source: OECD information and proprietary analysis by OIReScon
Additionally, we develop personalized analysis and strategies that integrate our data into each company's internal systems, from Business Intelligence platforms to CRM environments, enabling anticipation of decisions, identification of purchasing patterns, and strengthening of commercial strategy.
In a market where information is abundant but quality is scarce, we provide vision, context, and method to convert public data into knowledge that drives sustainable and long-term decisions.
Validated Data by the Industry
The reliability of our data is based on its source: official sources such as Procurement Platforms, Contractor Profiles, and Official Bulletins (DOUE, BOE, and regional and provincial bulletins)
Our classifications and analytical models have been audited and endorsed by reference entities such as Fenin(Spanish Federation of Health Technology Companies) and BioSim (Spanish Association of Biosimilars).
This recognition ensures that you access verified, accurate, and comparable information, capable of strengthening your company's competitiveness in the public healthcare market.
Talk to our experts
Find out how we can help you achieve your goals in the
healthcare market.